Clinical Discussions in Antithrombotic Therapy Management in Patients With Atrial Fibrillation: A Delphi Consensus Panel

Clinical Discussions in Antithrombotic Therapy Management in Patients With Atrial Fibrillation: A Delphi Consensus Panel

Background: In recent years, direct-acting oral anticoagulants (DOACs) have entered clinical practice for stroke prevention in non-valvular atrial fibrillation or prevention and treatment of venous thromboembolism. However, remaining uncertainty regarding DOAC use in some clinical scenarios commonly...

Full description

Bibliographic Details
Main Authors: Nicola Mumoli, MD, Claudia Amellone, MD, Gianfranco Antonelli, MD, Giuseppe Augello, MD, Cosima Cloro, MD, Alberto D’Alleva, MD, Leonardo Di Ascenzo, MD, PhD, Egidio Imbalzano, MD, Renato Masala, MD, Graziano Riccioni, MD, Emanuele Romeo, MD, Luca Rossi, MD, Giosuè Santoro, MD, Edoardo Sciatti, MD, Antonio Tondo, MD, Elisabetta Toso, MD, Elio Venturini, MD, Enrico Vizzardi, MD, Giosuè Mascioli, MD
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X20301116

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X20301116

Similar Items